CanadaBis Capital Inc CNADF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.07
- Day Range
- $0.07–0.07
- 52-Week Range
- $0.03–0.25
- Bid/Ask
- $0.02 / $0.06
- Market Cap
- $8.99 Mil
- Volume/Avg
- 106,250 / 33,526
Key Statistics
- Price/Earnings (Normalized)
- 2.78
- Price/Sales
- 0.58
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.canadabis.com
Valuation
|
Metric
|
CNADF
|
|---|---|
Price/Earnings (Normalized) | 2.78 |
Price/Book Value | 2.36 |
Price/Sales | 0.58 |
Price/Cash Flow | 2.66 |
Price/Earnings
CNADF
Financial Strength
|
Metric
|
CNADF
|
|---|---|
Quick Ratio | 0.49 |
Current Ratio | 1.24 |
Interest Coverage | 8.05 |
Quick Ratio
CNADF
Profitability
|
Metric
|
CNADF
|
|---|---|
Return on Assets (Normalized) | 15.74% |
Return on Equity (Normalized) | 96.84% |
Return on Invested Capital (Normalized) | 28.21% |
Return on Assets
CNADF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hxywdwzb | Hnlp | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Hrqfrzqvx | Dsqnkd | $70.9 Bil | |
HLN
| Haleon PLC ADR | Shgrttkx | Jjdg | $37.8 Bil | |
VTRS
| Viatris Inc | Mntznzpq | Ffdl | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mbdzztpf | Rqmxw | $12.7 Bil | |
CTLT
| Catalent Inc | Jbdzffmk | Qrmlfg | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Mzvgcgqq | Jkl | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Lqklgczy | Hvgnv | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dxfgydfk | Whtcyy | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Rtppnhyh | Rzdz | $3.1 Bil |